检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

RG6333 (CD19-CD28), a CD19-Targeted Affinity-Optimized CD28 Bispecific Antibody, Enhances and Prolongs the Anti-Tumor Activity of Glofitamab (CD20-TCB) in Preclinical Models

Johannes Sam,Thomas Hofer, Christine Kuettel,Christina Claus,Sylvia Herter,Guy Georges, Jenny Tosca Thom,Leo Kunz, Samuel Gebhardt,Florian Limani,Stefanie Briner, Silvia Jenni,Anne Schönle,Marine Le Clech,Ahmet Varol,Esther Bommer, Birte Appelt,Sara Colombetti,Stephan Gasser,Marina Bacac

Blood（2022）

引用 2|浏览13
暂无评分
关键词
cd19-cd28 bispecific antibody,glofitamab,affinity-optimized,anti-tumor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要